Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enabling a Paradigm Shift: A Preference-Tolerant RCT of Personalized vs. Annual Screening for Breast Cancer (Wisdom Study)

NCT02620852 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT02620852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02620852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enabling a Paradigm Shift: A Preference-Tolerant RCT of Personalized vs. Annual Screening for Breast Cancer (Wisdom Study)
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Recruiting
Start date
August 31, 2016
Completion date
September 30, 2029
Enrollment
100,000 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast cancer screening, breast carcinoma in situ